Introspectra prototype
Statusprototype
Corpus16 records
Reviewpending

Introspectra

Preparation, integration, and a reference library where nothing is published without a source.

Five domains, with citation permitted in one direction only. A safety page may draw on clinical and mechanism records. Nothing in safety, clinical, or mechanism may draw on a report. The rule is enforced in the database rather than by editorial discipline — which means a claim cannot quietly become a fact by being linked to often enough.

Select a domain to see what it may draw on.

SourcePubMed
Retrieved2026-10-15
Generatednone

The corpus

Sixteen records pulled through the ingestion pipeline. Every DOI is real and resolvable; no field was written by hand or produced by a model. The full queries returned 221 psilocybin trials and meta-analyses, 957 mescaline pharmacology records, and 661 for DMT — this is a working sample, not the library.

COMPOUND
EVIDENCE

Fieldstudy_type
Shownevery record

Where a finding sits, before you read it

Most writing in this field either overstates the science or dismisses it. The ladder appears on every clinical record, first, rather than as a caveat at the bottom.

case reportOne person, no control. A thing that happened.
observationalA pattern across people who were not assigned.
open-labelEveryone knew what they were taking.
randomisedAssigned by chance, outcome measured blind.
meta-analysisMany trials, pooled.

And on mechanism, a second axis

Mechanism is where overclaiming lives. A record states its distance from a human being, so it grows new neurons cannot pass as a human finding when it is a rodent one.

in vitroCells in a dish.
rodentMouse or rat.
primateNon-human primate.
human imagingLiving human brain, observed.
human clinicalHuman outcome, measured.
Programacademy
Audiencelicensed
Statusin build

The Academy

The same sourcing effort, packaged for professionals. Licensed counselors, social workers, and nurses must purchase continuing education every renewal cycle, and almost nobody offers accredited psychedelic pharmacology or harm reduction content. Co-instructed by the Foundation's pharmacologist.

01

Pharmacology

Structure–activity across the tryptamine and phenethylamine scaffolds; receptor profiles; what differentiates compounds.

02

Pharmacokinetics

Prodrugs, metabolism, duration, tolerance, and why oral DMT requires MAO inhibition.

03

Risk and contraindication

Cardiac, psychiatric, pregnancy, HPPD. Serotonergic interaction classes in detail.

04

Reading the evidence

What the trials actually show, how to place a finding, and where the literature is thinner than the coverage suggests.

05

Preparation

Screening, medication review, and the conversation before.

06

Integration

What the weeks after ask for, and recognising when to refer.

Licensable to training programs and clinics that need vetted curriculum they did not have to build, with updates as the literature moves.

Shapecountdown
Firstpsilocybin

Preparations for departure

A countdown rather than a list of topics, because the questions that matter change depending on how far out you are. A shared spine, with a module per compound layered on top.

T−30d

Whether at all

Medical screening, medication review, personal and family psychiatric history.

T−7d

Arrangements

Who will be there. Testing. What the day after looks like before you need it to.

T−24h

Last checks

Dietary and medication interactions, sleep, final contraindication pass.

T+24h

After

Rest, food, and writing it down before it thins out.

T+30d

Settling

What held, what did not, and what to watch for.

Two standing decisions: ibogaine has no preparation page, because a well-made one would imply it can be prepared for alone — its entry is why it requires cardiac screening and supervision. And for ayahuasca, the interaction list is the page, not a footnote.

Rulezero
Citations0

What an unfinished record looks like

No field is filled with a plausible guess. Until a value arrives from a named source with a retrieval date, it shows as missing. Showing that honestly is the point.

Psilocybin — receptor binding profile

awaiting ingestion
compound
Psilocybin — prodrug
structure
pending PubChem
5-HT2A Ki
pending NIMH PDSP
translational
not yet assigned
reviewed by
pending
This record has no citations and would not render publicly. It appears here to demonstrate the constraint.
Modesafety
Targetunder 100kb
Workswithout js

Safety

One tap from every page. Built to be read in the dark, on a bad connection, by someone who is not calm.

If someone is unresponsive, call emergency services

Tell them what was taken if you know. You will not be arrested for calling.

  • Check interactions

    Substance and medications. Sources shown with each result. When sources disagree, the most cautious is shown and the disagreement stated. Nothing you enter is logged.

  • Serotonergic medications

    The most common dangerous interaction, and the one most often missed.

  • Testing what you have

    Reagent kits, fentanyl strips, and what testing cannot tell you.

  • Supporting someone in distress

    What helps, what makes it worse, and when to escalate.

  • Breathing to settle

    Slow paced breathing. Not retention, not intensive work.

Severity is carried by weight and order, not colour. A red badge fails a colourblind reader and reads as a dashboard. The heaviest thing on the page is the most important thing on the page.